Talk DIAlogue Sessions track
S1103 - DIA Projects Around the World
Wed, Mar 19, 2025 · 3:00–4:10 PM CET Shanghai 1-2 Room, Congress Center Basel
About this session
This session highlights the 2025 DIA Science Priorities and discusses the results of some of the recent public private partnerships our organization has convened and is currently managing through collaborative problem-solving. Through structured dialogue, we will share the insights from these initiatives and how the frameworks have now been created to tackle pressing challenges in AI implementation, patient reimbursement and clinical trial recruitment, as well as taking the patient voice into consideration while considering new therapies for regulatory approval.
This solutions-focused session offers unique opportunities to engage directly with DIA and other thought leaders from across the medical product development continuum while building valuable connections across the healthcare ecosystem with stakeholders from the pharmaceutical, biotechnology, nonprofit, academic, and technology sectors.
Programme:
- 1. Welcome and Overview of the Global Priorities for DIA 2025 — Maria Vassileva
- 3. DIA Research Study Aiming to Define Treatment Tolerability in Cancer Care — Maria Paula Bautista, Paul Cordero
- 2. DIA AI Consortium: Bringing Together Regulators and Experts from the Pharmaceutical Industry and Technology Sectors — Stephanie Rosner, Sridevi Nagarajan
- 4. NextGen Project Consortium — Philippe Page
Speakers
-
Clinical Outcomes Assessment Lead · Sanofi
Speaker
-
Scientific Project Manager · DIA
Speaker
-
Scientific Program Manager, Artificial Intelligence · DIA
Speaker
